REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$807.65
arrow_downward
-0.33%(-2.66) 1D
$807.65
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 9, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$803.83
High
$808.63
Low
$796.72
Mkt. cap
83.15B
Avg. vol.
754.42K
Volume
0.00
Dividend
0.47%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.97
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
Open
$803.83
High
$808.63
Low
$796.72
Mkt. cap
83.15B
Avg. vol.
754.42K
Volume
0.00
Dividend
0.47%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.97
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
PR Newswire
·
4 hours ago
REGN MONDAY DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
PR Newswire
·
8 hours ago
REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Fraud Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure
Yahoo Finance
·
14 hours ago
Here’s Why The Fund Sold Regeneron Pharmaceuticals (REGN)
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com